Lab Notes: FDA approves Incyte's vitiligo treatment; Neuronetics gets a 'big win'
July 22, 2022 at 13:51 PM EDT
A Bucks County biopharma firm has an update on its pursuit of a hepatitis B therapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.